Having established the efficacy of the FBP9R-mediated siRNA delivery system in targeting Fas-mediated apoptosis and Bax, we investigated the therapeutic implications in the context of cerebral ischemia modeled by the MCAO model. The gene discussed is FAS; the disease is brain ischemia.